Eugene Leibovitz spends much of his time researching Internal medicine, Antibiotics, Streptococcus pneumoniae, Antibacterial agent and Surgery. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Moraxella catarrhalis and Pneumococcal infections. He regularly ties together related areas like Carriage in his Antibiotics studies.
His Streptococcus pneumoniae study integrates concerns from other disciplines, such as Immunology, Otitis, Haemophilus influenzae and Drug resistance. His Antibacterial agent research incorporates elements of Amoxicillin, Chemotherapy, El Niño, Pharmacotherapy and Azithromycin. His work in the fields of Surgery, such as Regimen, intersects with other areas such as Systemic candidiasis.
Eugene Leibovitz mainly focuses on Internal medicine, Streptococcus pneumoniae, Antibiotics, Immunology and Pediatrics. His Internal medicine research includes elements of Gastroenterology and Surgery, Otitis. His biological study spans a wide range of topics, including Penicillin, Serotype and Haemophilus influenzae.
His Antibiotics research is multidisciplinary, incorporating perspectives in Drug resistance and Intensive care medicine. He studied Immunology and Neutropenia that intersect with Leukopenia. His Pediatrics research integrates issues from Retrospective cohort study, Epidemiology, Incidence and Pneumonia.
Eugene Leibovitz mainly investigates Pediatrics, Internal medicine, Incidence, Epidemiology and Streptococcus pneumoniae. His Pediatrics research incorporates themes from Mastoiditis, Antibiotics, Disease and Retrospective cohort study. The concepts of his Internal medicine study are interwoven with issues in Ceftriaxone, Brucellosis and Otitis.
His work deals with themes such as Surgery, Headaches and Intensive care medicine, which intersect with Epidemiology. His research on Streptococcus pneumoniae often connects related topics like Serotype. In his study, Campylobacter Gastroenteritis and Pneumococcal infections is inextricably linked to Immunology, which falls within the broad field of Pneumonia.
Eugene Leibovitz mainly focuses on Pediatrics, Streptococcus pneumoniae, Antibiotics, Epidemiology and Incidence. His studies deal with areas such as Serotype, Haemophilus influenzae and Otitis as well as Streptococcus pneumoniae. His Otitis research is multidisciplinary, relying on both Pneumococcal 7-Valent Conjugate Vaccine, Pneumococcal conjugate vaccine and Internal medicine.
Antibiotics is a subfield of Microbiology that Eugene Leibovitz explores. The Microbiology study combines topics in areas such as Shigella and Immunology. His work carried out in the field of Epidemiology brings together such families of science as Surgery and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population.
Ron Dagan;Noga Givon-Lavi;Eugene Leibovitz;David Greenberg.
The Journal of Infectious Diseases (2009)
Prospective Study To Determine Clinical Relevance of Detection of Pneumococcal DNA in Sera of Children by PCR
Ron Dagan;Ofra Shriker;Inbal Hazan;Eugene Leibovitz.
Journal of Clinical Microbiology (1998)
Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media.
Ron Dagan;Candice E. Johnson;Samuel Mclinn;Nazha F Abughali.
Pediatric Infectious Disease Journal (2000)
Haemophilus influenzae: a significant pathogen in acute otitis media.
Eugene Leibovitz;Michael R Jacobs;Ron Dagan.
Pediatric Infectious Disease Journal (2004)
Recent advances in otitis media.
Stephen I. Pelton;Eugene Leibovitz.
Pediatric Infectious Disease Journal (2009)
Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Ron Dagan;Oren Abramson;Eugene Leibovitz;Ruth Lang.
Pediatric Infectious Disease Journal (1996)
Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome.
Ron Dagan;Eugene Leibovitz;David Greenberg;Pablo Yagupsky.
Pediatric Infectious Disease Journal (1998)
Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.
Ron Dagan;Alejandro Hoberman;Candice Johnson;Eugene L. Leibovitz.
Pediatric Infectious Disease Journal (2001)
Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.
Shalom Ben-Shimol;Noga Givon-Lavi;Eugene Leibovitz;Simon Raiz.
Clinical Infectious Diseases (2014)
Bacteriologic Efficacies of Oral Azithromycin and Oral Cefaclor in Treatment of Acute Otitis Media in Infants and Young Children
Ron Dagan;Eugene Leibovitz;Dan M. Fliss;Alberto Leiberman.
Antimicrobial Agents and Chemotherapy (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: